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ABSTRACT
Objectives To test the impact on family carers
of a Carer Support Needs Assessment Tool
(CSNAT) intervention to facilitate carer-led
assessment and support during end of life care.
Method Mixed method, part-randomised,
stepped wedge cluster trial with 6 palliative
home care services comparing carers receiving
the intervention with those receiving standard
care. Postal survey with carers 4–5 months
postbereavement measured adequacy of end of
life support, current mental and physical health
(Short Form 12 Health Survey SF-12), level of
grief (Texas Revised Inventory of Grief, TRIG) and
distress (Distress Thermometer, DT), place of
death and carer satisfaction with place of death.
Results Surveys were sent to 3260 (76%) carers
of 4311 deceased patients; 681 (21%) were
returned (N=333 control, N=348 intervention).
Compared with controls, intervention carers had
significantly lower levels of early grief, better
psychological and physical health, were more
likely to feel the place of death was right, and
patients were more likely to die at home.
However, differences were small and process
measures showed low level of implementation,
indicating differences may partially relate to
increased awareness of carer issues rather than a
direct impact of the intervention.
Conclusions Carers had better outcomes in the
intervention condition, albeit modest. If this can
be achieved through low level implementation
and awareness raising of carers’ needs from
implementation activities, substantial impact
should be possible if the CSNAT intervention can
be fully implemented with a majority of carers.
The study illustrates challenges of implementing
and testing a complex intervention in real-life
practice and of achieving comprehensive carer
assessment and support in line with government
recommendations.
INTRODUCTION
Family carers are central to enabling
patients to remain at home at end of
life.1 2 However, carers may suffer worse
physical and psychological well-being
prebereavement and postbereavement
from care giving.3 4 Better support for
carers may promote better bereavement
outcomes,5–7 improved quality of care
for patients8 and plausibly, increase likeli-
hood of death at home. To ensure that
carers’ support needs are assessed and
addressed9 10 we developed a Carer
Support Needs Assessment Tool
(CSNAT) in collaboration with the
National Association for Hospice at
Home to provide an evidence-based carer
assessment tool suitable for practice.11
The CSNAT consists of 14 items repre-
senting broad domains with which carers
require support during care giving at end
of life. These include support to help
carers support the patient, for example,
with knowing what to expect, who to
contact, how to manage symptoms and
medicines; and support for carers them-
selves, for example, with feelings and
worries, daytime or night time respite.
The CSNAT enables carers to identify
and prioritise domains where they need
more support and then determine, in dis-
cussion with a practitioner, what they
would find helpful to address needs. This
constitutes the CSNAT intervention,
a process facilitated by practitioners, but
led by carers. Desired support may
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include help practitioners can provide immediately
(eg, reassurance, advice, information), help to involve
other family members, signposting towards external
support or referral for further input. The CSNAT
domains were developed from focus groups and inter-
views with 75 bereaved carers11 and their face and cri-
terion validity tested with 225 current carers.12
Piloting and feasibility work with practitioners
showed perceived benefits of the CSNAT intervention
and also some challenges of implementation that
informed further CSNAT training and support.13 14
While promising, the CSNAT intervention required
further testing to establish whether it improved carer
outcomes. However, high demand for an evidence-
based carer assessment tool among our service part-
ners and their belief in the benefits of the CSNAT
intervention made it difficult to conduct a conven-
tional randomised controlled trial. Randomising indi-
viduals within services to the control arm was likely
to be seen as unacceptable and also entail risk of
cross-contamination between intervention and
control arms. Similarly, if services were assigned to a
‘control cluster’ they were more likely to disengage.
Instead a stepped wedge trial design, a variant of the
cluster trial, enabled us to build a robust evaluation
around a ‘controlled’ release of the intervention into
practice in a situation where providers were keen to
start using the CSNAT,15 and to capitalise on the
natural experiment this offered.16 Stepped wedge
cluster designs are recommended where there is
strong belief in the benefits of the intervention, its
costs are low and side effects unlikely.17 18 Further,
stepped wedge designs are suited to situations where
geographical and pragmatic constraints prevent simul-
taneous implementation across study settings, and
allows all participating sites to eventually use the
intervention, thus preventing the disengagement
within control sites which may be a problem in con-
ventional cluster trials.17 18
METHODS
Study design
A stepped wedge cluster part-randomised trial17 18
was used to test the impact of the CSNAT interven-
tion on carer and patient outcomes. The clusters were
six palliative home care sites (table 1). Sites started
using the intervention one by one at three monthly
intervals, the time before the intervention represent-
ing their control period (table 2). Site practitioners
would start using the CSNAT intervention with all
carers of patients on their caseload from their inter-
vention start date. All carers of patients who died
before this date would only have received the usual
service input and so were part of the control condi-
tion. After the intervention start date, all carers
should have had the opportunity to receive the
CSNAT intervention, so carers of patients who died
after this date were part of the intervention condition.
This was therefore a repeated cross-section stepped
wedge design with different individuals in each cluster
in the preintervention and postintervention steps.17
Pragmatic constraints meant the sequence of sites
beginning the intervention was not fully randomised;
the sites most and least ready to fit in a practice change
at study start were allocated to begin the intervention
first (CSNAT intervention only) and last (control
only), respectively, in the implementation sequence.
The remaining sites were allocated to begin treatment
in a randomised sequence in between these two (table
2). Delivery of the CSNAT intervention was recorded to
monitor level of implementation, including any transi-
tion periods while the intervention was ‘bedding in’.
Carer outcomes were obtained through survey of
carers postbereavement, to allow assessment of longer
Table 1 Characteristics of trial services
Site Participating service
Practitioners within teams
(outset of study)
Deaths per
month (prestudy info)
1 Home care team, two components: 1 Home care team manager 34
Specialist Palliative Care Team
Palliative Care Support Team
8 CNSs
7 RGNs
6 HCAs
2 Home care team, two components 40
CNS team 1 CNS team manager
5 CNSs
Hospice at home team I CNS
3 RGNs
9 HCAs
3 Hospice at home service—two teams covering different geographical areas 18 CNSs (9 for each geographical area) 50
4 Community Nurse Specialist Team 26 CNSs 100
5 Community Palliative Care Nurse Specialist Team 1 Manager
8 CNSs
25
6 Palliative Home Nursing Service 1 Community team leader
5 CNSs
30
CNS, clinical nurse specialist; HCA, healthcare assistant; RGN, registered general nurse.
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term impact and measurement of outcomes relative to
a common ‘anchor point’, enabling consistent cross-
comparison between carers. Earlier psychometric
testing of the CSNAT12 showed predeath outcome
measures to be strongly influenced by variations in
patients’ stage of illness and proximity to death.
Postbereavement measurement furthermore meant
outcome data collection proceeded a step behind, and
was managed separately from, practice delivery of the
intervention, so assessment was fully blinded and
intervention and data collection activities did not
interfere with each other. Ethics approval was
obtained from NRES Committee North West—
Greater Manchester East (12/NW/0206).
Implementation of the CSNAT intervention
Implementation required both external facilitation by
the research team and internal facilitation by sites,
informed by prior pilot and feasibility studies.13 14
External facilitation ensured aims and requirements
for implementation and the trial were established
through documentation and meetings with service
managers, lead practitioners and administrators.
Training was conducted with all staff involved in the
intervention, consisting of two sessions of 2 h 1 week
apart. Session 1 covered reflection on current carer
assessment, introduction of the CSNAT intervention
and how it differed from current practice. Session 2
covered how practitioners could use the intervention
during carer contacts and how it would integrate with
existing administration, recording and service proce-
dures. A service lead practitioner led the latter com-
ponent. Each service nominated 1–2 CSNAT
Champions to lead the CSNAT implementation.
These were supported through regular contacts with
the Research Associate (RA), monthly Skype meetings
with Champions at other participating sites and two
cross-site Champion face-to-face meetings. Research
team members met with practitioners involved in the
intervention 1–2 months after start of implementation
to identify and address any queries. The RA liaised
several times per month with core team members to
discuss and resolve ongoing issues. A website provided
documentation and further means of communication.
Internal facilitation included organisational prepar-
ation, formation of a core team (champion, manager,
administrator) to steer implementation, adoption of a
change management approach and enhancing mutual
practitioner support.
Recruitment
Site administrators identified name and contact details
of the main carer or next-of-kin (NOK) of all patients
who died during the trial period (representing the
total sampling frame). Survey packs were sent to
carers 4–5 months postbereavement. Previous research
indicates 4–6 months may yield the best response
rates, while avoiding the period of most intense griev-
ing,19 but hopefully preserving accuracy of recall.
Exclusion criteria were carer age <18 years or being
identified by site practitioners as experiencing particu-
larly complicated grief. Administrators recorded
surveys sent and reasons for any exclusions.
Survey packs contained an invitation letter from the
service, participant information sheet, consent forms,
a questionnaire booklet and freepost envelope. Carers
sent completed surveys to the RA.
Data from previous cross-sectional hospice home
care research6 showed a difference of 8.7 (SD 12.6) in
postbereavement SF-36 mental health scores between
carers who reported sufficient psychological support
during end of life care and those who did not, repre-
senting a standardised effect size of 0.69. However,
cross-sectional designs may inflate effect size. For the
trial, we assumed an effect size of half of this would
be more realistic (0.345). The need to reduce survey
response burden furthermore led to a switch to the
shorter SF-12 mental health scale. Based on
Monte-Carlo simulation a stepped wedge trial with
six clusters (sites) with five time bands (steps) and on
average 18 patients per time band per cluster
(N=540) should have 80% power to detect a standar-
dised effect of 0.345 assuming an intracluster correl-
ation of 0.05 and a 5% significance level. Early data
from participating sites indicated they had N=3600
deaths over 15 months, making the required carer
sample of N=540 feasible even with high exclusion
(0.20) and low response rates (0.25).
Table 2 Stepped wedge trial: deaths (% survey sent/% survey response rate) by trial site, time interval (step) and trial arm (intervention:
shaded; control: blank)
Step 1 2 3 4 5 Total Total control Total intervention
Site
1 108 (66/20) 109 (82/25) 127 (69/23) 115 (79/25) 106 (75/15) 565 (74/22) 565 (74/22)
2 91 (65/31) 131 (61/25) 126 (56/30) 127 (54/20) 142 (54/25) 617 (58/26) 91 (65/31) 526 (56/25)
3 98 (74/29) 104 (77/30) 89 (74/30) 97 (85/28) 101 (80/21) 489 (78/27) 202 (76/29) 287 (80/26)
4 305 (82/22) 312 (87/16) 335 (80/18) 301 (81/27) 278 (75/20) 1531 (81/21) 952 (83/19) 579 (78/24)
5 142 (93/23) 115 (88/16) 114 (89/15) 98 (87/11) 86 (77/21) 555 (88/17) 469 (90/17) 86 (77/21)
6 160 (82/12) 146 (67/13) 83 (72/15) 74 (41/13) 91 (60/18) 554 (67/14) 554 (67/14)
Total 904 (79/21) 917 (78/19) 874 (75/20) 812 (74/23) 804 (71/20) 4311 (76/21) 2268 (79/19) 1478 (72/24)
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Data collection
Sampling frame information
Site administrators completed monthly spreadsheets
from service records for all patient deaths during the
trial to compile the study sampling frame. This
included study ID number, patient age, gender, diag-
nosis, date and place of death; and the name and
contact details of main carer or NOK, their gender
and relationship to the patient to enable identification
of carers for the survey. Anonymised information
from the sampling frame was provided for analysis.
Data could be linked to individual survey respondents
with their consent.
Outcome variables
The survey collected information on carers’ age,
gender and relationship with the patient.
Primary outcome survey measures comprised
adequacy of support provided for the carer during end
of life care giving and physical and psychological well-
being in bereavement. Perceived adequacy of support
was measured using 14 questions based on the CSNAT
domains, using the format ‘Did you need more
support with—’ (responses: 1—no; 2—a little more;
3—quite a bit more; 4—very much more). Scores were
summarised for the analysis. A further three questions
asked whether carers had been asked about their
support needs, felt their needs had been listened to,
and whether there were concerns they had been
unable to discuss (responses: 1—always, 2—usually, 3
—sometimes, 4—never). Level of grief in bereavement
was measured using the Texas Revised Inventory of
Grief (TRIG)20 which covers early (immediately after
death) and current grief. Psychological and physical
well-being was measured using the SF-12v2,21 and
distress using the Distress Thermometer (DT).22
General practitioner (GP) contacts postbereavement
were collected as a further indicator of physical health.
Secondary outcome survey measures were place of
death (home, hospice, hospital, nursing/ residential
home, other) and whether the place of death was felt
to be the best place (yes, no, mixed feelings, don’t
know). Information on place of death on all patients
was furthermore provided through the sampling
frame information on place of death. Place of death
was dichotomised into ‘home’/‘not home’.
Process data on implementation of the intervention
Administrators provided monthly summaries on
number of new patients, patients on the caseload and
number of CSNAT assessments completed for new
patients and total caseload. They also recorded which
carers had a CSNAT intervention on the site
spreadsheet.
Qualitative information on implementation was
collected from practitioners through face-to-face
interviews, focus groups and workshops. In addition,
field notes were completed of all RA contacts with
participating sites to form a ‘diary’ of activity relating
to the implementation. Qualitative findings will be
reported in detail elsewhere.
Analysis
Response modelling
Factors affecting survey response rates were investi-
gated using a logistic mixed-effects model. This
included a random effect for site and a fixed effect for
time (see below). All available patient and carer data
from service records were examined as predictors for
survey response. These were: carer gender; the rela-
tionship of patient to carer; patient age, and patient
diagnosis. The intracluster correlation coefficient was
also estimated to assess the strength of response clus-
tering between carers of patients from the same site.
Outcomes
Analyses to test for differences in outcomes between
control and intervention groups were based on inten-
tion to treat (ie, included all intervention participants
whether they received the CSNAT intervention or
not) and were adjusted for site, patient and carer vari-
ables. Outcomes were analysed using mixed-effects
models to account for the stepped-wedge cluster-
randomised trial design, by including a random effect
for site and a fixed effect for time.23 For quantitative
and summary score outcomes, linear mixed effect
models were used. To assess the number of carer GP
contacts since patients’ death, a Poisson mixed-effects
model was used; the rate ratio was estimated to evalu-
ate the intervention effect. For questions with ordinal
responses, a cumulative logistic mixed-effects model
was used, under the proportional odds assumption.
For secondary binary outcomes, a logistic
mixed-effects model was used. Both logistic and
cumulative logistic models provided estimates of the
intervention effect via an OR.
All analyses of outcomes included adjustment for
carer gender, the relationship of patient to carer
(partner/parent/sibling/other), patient age and diagno-
sis (cancer/other). For variables obtained from both
service records and surveys (carer gender, relationship
between patient and carer and place of death) unavail-
able data in service records were imputed from avail-
able survey response data and vice-versa. For analyses,
any remaining missing categorical covariate values
were imputed as a separate ‘unknown’ category value
and missing continuous covariate values were imputed
using simple conditional mean imputation.24 The stat-
istical significance of intervention effects was inferred
from the likelihood ratio test, and 95% CIs of inter-
vention effect estimates were constructed with normal
(Wald) approximations.
RESULTS
Sample
There were large differences in sample sizes across
sites supporting the appropriateness of incorporating
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clustering by site in all analyses. There were no
obvious imbalances of carer/patient characteristics
between control and intervention arms (table 3).
One site initially had two separate, but collaborating
services included in the trial. However, the smaller
service was withdrawn after some months as coordin-
ation procedures were not felt to work well enough to
fully guarantee that a carer would not be sent the
survey twice. This represented removal of 265 deaths
from the initial sampling frame.
There were 4311 deaths in the remaining participat-
ing services during the trial (2268 control, 1478 inter-
vention; table 3). Surveys were sent to carers in 3260
(76%) cases. A main recorded reason for not sending
a survey was missing or incomplete carer details (439/
1051; 42%; as opposed to ‘no carer’). Of surveys
sent, 681 (21%) were returned. Forty-eight respon-
dents (7%; 22 control, 26 intervention) did not
enclose consent to link their survey and service record
data, and the data of the latter were imputed for the
analysis (see Analysis). Table 2 shows details of patient
deaths and surveys sent.
There was a wide range in the unadjusted survey
response rates across sites. There was some evidence
for difference in response rate by certain predictors.
The independent OR estimates (95% CI) for survey
response in (1) the intervention arm compared with
control, (2) female carers compared with male carers
and (3) carers of patients diagnosed with cancer com-
pared with those with other diseases were 1.30 (0.92
to 1.82) and 1.14 (0.93 to 1.40) and 1.00 (0.75 to
1.34), respectively. There was no statistically signifi-
cant effect for a difference in response rate across
time/phase. Compared with carers who were partners
of patients, the OR estimates (95% CI) of carers
recorded as being (1) parents, (2) siblings or (3) other
of patients were 0.92 (0.73 to 1.15), 0.93 (0.50 to
1.73) and 0.48 (0.27 to 0.85), respectively. Once
these predictors were adjusted for, the variation across
sites was small; the intraclass correlation coefficient
within site was estimated to be 0.017, indicating a low
clustering effect of site on the response rate.
Outcomes
Table 4 shows observed, unadjusted primary and sec-
ondary outcomes by trial arm. Relative to carer survey
reports, services slightly over-reported deaths at
home, but this effect appeared similar for control and
intervention patients. Table 5 shows adjusted estimates
of the effect of the intervention on outcomes.
In the intervention group, there was evidence of
reduction in early grief (TRIG-1) and improvements
Table 3 Patient and carer characteristics
Characteristics of patients and carers associated with all
deaths at trial sites (n=4311, nC=2268, nI=2043)
Characteristics of patients and carers in survey response sample
(n=681, nC=333, nI=348)
All deaths Missing Control Missing Intervention Missing
Carer gender (%)
Male 1322 (34) 440 (12) 101 (33) 24 (8) 90 (29) 35 (11)
Female 2549 (66) 208 (67) 223 (71)
Patient relationship to carer (%)
Partner 2248 (56) 302 (7) 208 (67) 22 (7) 222 (69) 26 (8)
Parent 1266 (32) 84 (27) 89 (28)
Sibling 127 (3) 8 (3) 6 (2)
Other 368 (9) 11 (4) 5 (2)
Mean patient age (SD) 73.4 (−12.1) 55 (1) 71.5 (−10.6) 24 (8) 72.2 (−12.2) 26 (8)
Patient gender (%)
Male 2269 (53) 48 (1) 142 (46) 22 (7) 147 (46) 26 (8)
Female 1994 (47) 169 (54) 175 (54)
Patient diagnosis (%)
Cancer 3701 (88) 87 (2) 271 (88) 26 (8) 282 (88) 28 (9)
Other 523 (12) 38 (12) 38 (12)
Carer gender (%)*
Male 109 (33) 5 (2) 97 (28) 5 (2)
Female 219 (67) 246 (72)
Patient relationship to carer (%)*
Partner 222 (67) 1 (0) 231 (67) 1 (0)
Parent 91 (27) 100 (29)
Sibling 5 (2) 6 (2)
Other 14 (4) 10 (3)
(Note: these summaries are unadjusted for sample sizes at each site and time).
*Data from survey responses, all other data from service records.
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in mental and physical health (SF-12) compared with
the control group, although improvements were at
most moderate. Most intervention effect estimates on
primary outcomes (7/10) were in a favourable direc-
tion even if not always statistically significant.
However, there was no indication that the interven-
tion group felt their needs had been met (CSNAT
total), or their support needs probed or listened to, to
a greater extent than the control group.
For survey respondents, there was evidence of a
favourable intervention effect on probability of death
at home and seeing the place of death as the best
place, with an OR of approximately 2 for each.
Although survey records for all deaths also indicate a
favourable effect on the probability of dying at home,
the adjusted analysis did not support this.
Implementation of the intervention
Monthly summaries of CSNAT assessments were
obtained from four of the five sites that began the
intervention during the trial, but to varying levels of
completeness. Three provided monthly data on
number of new patients, and CSNATs handed out and
completed for carers of new patients. Two of these
services also provided data on total numbers on case-
load, and total CSNATs handed out and completed
Table 4 Observed outcomes in the survey response sample (n=681, nC=333, nI=348)
Outcome Control Missing (%) Intervention Missing (%)
CSNAT total (SD) 20.9 (−7.6) 17 (5) 21 (−7.4) 14 (4)
Asked about support needs (%)
‘Never’ 31 (10) 9 (3) 25 (8) 17 (5)
‘Sometimes’ 53 (18) 78 (26)
‘Usually’ 56 (19) 71 (23)
‘Always’ 132 (44) 106 (35)
‘Not applicable’ 30 (10) 25 (8)
Listened to (%)
‘Never’ 12 (4) 10 (3) 14 (5) 15 (5)
‘Sometimes’ 24 (8) 25 (8)
‘Usually’ 46 (15) 69 (22)
‘Always’ 182 (60) 177 (57)
‘Not applicable’ 37 (12) 22 (7)
Unable to discuss concerns (%)
‘Always’ 3 (1) 20 (6) 2 (1) 26 (8)
‘Usually’ 8 (3) 8 (3)
‘Sometimes’ 56 (19) 61 (21)
‘No never’ 203 (70) 198 (67)
‘Don’t know’ 21 (7) 27 (9)
TRIG-1 early grief (SD) 23.3 (−8.2) 17 (5) 21.7 (−7.7) 15 (5)
TRIG-2 present grief (SD) 49.9 (−11.4) 12 (4) 48.4 (−11.2) 6 (2)
SF-12 mental (SD) 39.2 (−11.8) 5 (2) 40.5 (−11.3) 7 (2)
SF-12 physical (SD) 48.5 (−11.7) 5 (2) 51.1 (−10.1) 7 (2)
Distress level (SD) 4.6 (−2.6) 2 (1) 4.4 (−2.7) 10 (3)
Median number of carer GP visits since death (range) 1 (0, 11) 8 (3) 1 (0, 12) 8 (2)
Place of death was best place (%)
Yes 224 (73) 3 (1) 261 (82) 3 (1)
Other 84 (27) 58 (18)
Place of death at home (survey) (%)
Yes 140 (45) 2 (1) 171 (53) 2 (1)
No 169 (55) 149 (47)
Place of death at home (service—respondents only) (%)
Yes 148 (48) 0 (0) 180 (56) 0 (0)
No 163 (52) 142 (44)
Place of death at home (service—all records) (%)
Yes 1040 (46) 23 (1) 1044 (52) 25 (1)
No 1206 (54) 973 (48)
Note: these summaries are unadjusted for sample sizes at each site and time and for other covariates.
CSNAT, Carer Support Needs Assessment Tool; GP, general practitioner; TRIG, Texas Revised Inventory of Grief.
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for total caseload. One provided information on
CSNATs handed out and completed, but not on the
denominators.
Based on available summary data, 985 CSNATs
were reported to have been handed out to carers, but
CSNAT assessments were completed in only 209
(21.2%) of these cases (range of completion across
sites: 13.7–56.3%). CSNATs were reportedly handed
out to 685 (41.6%) carers of 1645 new patients, and
completed for 113 of these (completion rate 16.5%).
Where total caseload numbers are available, CSNATs
was handed out to 789 (32.1%) of 2461 on total case-
load (completion rate 20.0%).
DISCUSSION
Results show that compared with the control group
the intervention group had small but significant reduc-
tions in levels of early grief and improvements in psy-
chological and physical health.
Correspondingly, results from Australia indicate that
CSNAT use may benefit carers and reduce carer
strain.25 26 Furthermore, among our survey respon-
dents, the intervention carers were significantly more
likely to feel the place of death was right and patients
more likely to die at home. However, the latter result
was not significant when considering service records
for all deaths (respondents, non-respondents and those
not surveyed). This may reflect underlying differences
between survey respondents and non-respondents, the
latter being a much larger group. Although not evident
by table 3, there may be differences in unrecorded
characteristics that, for example, may make home
death both more likely and more responsive to the
intervention condition in the survey group.
Overall, there appears to be favourable effects of
the intervention, but differences were small, and inter-
vention carers were not more likely to feel their needs
had been met. However, the process data indicate that
implementation of the CSNAT intervention was
limited, both in terms of numbers of carers affected
and the extent to which the intervention was delivered
as intended. Available data indicate that the CSNAT
was only handed out to carers of a third of patients in
total. Furthermore, while a reasonable proportion of
carers may have seen the CSNAT, potentially along-
side other paperwork, CSNAT assessment was only
completed in a minority of cases. Completion in itself
may not mean there was subsequent discussion about
carers’ needs, priorities and preferred solutions and
follow-up action plans. This low level of implementa-
tion means the CSNAT intervention would have
limited opportunity to make a strong direct impact.
Improvements in the intervention group may there-
fore in part result from awareness raising regarding
carers’ needs through activities surrounding the imple-
mentation of the intervention, including training,
champions’ efforts, regular RA contacts, keeping
CSNAT on staff meeting agendas and encouragement
by managers. However, if significant improvements,
albeit small, may be produced by low level implemen-
tation and general awareness raising, it is plausible
that more substantial improvements can be achieved if
the CSNAT intervention can be delivered to the
majority of carers in its intended form, that is, an
assessment and support process based on carers’ self-
identified needs, priorities and solutions.
While there was no doubt about efforts expended
by sites participating in the trial, implementation of
Table 5 Estimate of effect of intervention with ICC on site
Outcome Intervention effect 95% CI p Value Favourable result ICC
Estimate of effect of intervention on quantitative or summary score outcomes (*Rate ratio from Poisson mixed-effects model, all other estimates from linear
mixed-effects models)
CSNAT total (n=646) −0.36 (−2.17, 1.44) 0.684 <0 0.108
TRIG-1 early (n=645) −1.96 (−3.83, −0.09) 0.038 <0 0.106
TRIG-2 present (n=659) −1.24 (−3.95, 1.47) 0.322 <0 0.204
SF-12 mental (n=666) 2.58 (0.00, 5.15) 0.049 >0 0.073
SF-12 physical (n=666) 3.09 (0.64, 5.53) 0.011 >0 0.105
Distress level (n=665) −0.18 (−0.79, 0.44) 0.508 <0 0.029
Number of GP visits since patient death (n=662) 1.02* (0.86, 1.20) 0.833 <1 0.000
Estimate of effect of intervention (proportional OR) on ordinal response outcomes (ICC calculated on latent scale)
Asked about support needs (n=595) 0.77 (0.47, 1.26) 0.38 >1 0.013
Listened to (n=591) 0.87 (0.51, 1.46) 0.600 >1 0.016
Unable to discuss concerns (n=577) 1.05 (0.55, 2.00) 0.890 >1 0.026
Estimate of effect of intervention (OR) on secondary binary outcomes (ICC calculated on latent scale)
Place of death was best place (n=673) 1.94 (1.06, 3.56) 0.033 >1 0.032
Place of death at home (survey), (n=675) 2.13 (1.25, 3.61) 0.006 >1 0.036
Place of death at home (service), (n=4263)‡ 0.957 (0.76, 1.20) 0.698 >1 0.029
‡Model fitted to all carer/patient records, not just survey respondents.
CSNAT, Carer Support Needs Assessment Tool; GP, general practitioner; ICC, intracluster correlation; TRIG, Texas Revised Inventory of Grief.
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the CSNAT intervention presented greater challenges
than expected. Qualitative data collection helped iden-
tify main factors that affected implementation, illus-
trating the value of a mixed-methods approach to
trials.27 While these factors will be reported in detail
elsewhere, in brief outline they encompassed practi-
tioner perceptions and engagement, service context
factors, external and internal facilitation: the CSNAT
intervention represented a step change in practice, but
practitioners may not perceive its value over existing
practice and/or have concerns over workload impact.
Services differed in the extent to which existing
administrative systems and working practices enabled
the CSNAT intervention to be easily integrated and
carers to be accommodated as clients in their own right.
This included existing opportunities for carer identifica-
tion, contact and recording of support needs and
actions. Internal facilitation was affected by time and
availability of management leads, champions’ oppor-
tunities for leverage and organisational resources to
support implementation in the face of competing
demands and staffing levels. External facilitation did
not fully address the step change that the intervention
represented. Our findings correspond with the com-
ponents of the Promoting Action on Research
Implementation in Health Services (PARIHS) frame-
work for implementation where implementation of a
complex intervention depends on the perceived value
of the intervention, service context and facilitation.28 29
The research was also affected by some of the
service factors. Missing information on main carers or
NOK increased administrator workloads in chasing
information, reduced numbers of surveys sent and left
less time for supplying process data. Lack of proce-
dures for routine recording of CSNAT assessments
and follow-up actions also hampered further collec-
tion and analysis of process information. Service
support costs for recruitment were fully covered, but
this was only helpful if services could appoint add-
itional staff. Services’ ability to fit in a practice change
at the time furthermore meant that (constrained) ran-
domisation only occurred in four of six participating
sites; therefore, some selection biases and imbalances
between the control and intervention samples are
possible.
CONCLUSION
The trial highlights the importance of investing effort
in understanding implementation of complex inter-
ventions as recommended by the MORECare guid-
ance for palliative care30 and the MRC Framework
for evaluations.31 Our trial furthermore illustrates the
value of mixed methods and process measures to
understand how complex interventions behave in a
practice context.27 31
Furthermore, the trial highlights the challenges in
implementing comprehensive carer assessment and
support: our qualitative data indicate that carers are
not ‘visible’ on administrative systems in that often
carer details are not recorded and there are commonly
no consistent means of documenting their needs as
separate from patients; that practice procedures often
do not afford opportunity for regular carer contact,
assessment and follow-up; and that engagement with
assessment of carers’ needs separately from the patient
and with carer-led assessment represents a significant
step change for practitioners. These challenges need
to be recognised and addressed before guidelines and
government recommendations that carer needs should
be assessed and addressed9 10 can have meaningful
impact. We have used trial findings to develop a train-
ing and implementation package to improve external
facilitation and encourage better internal facilitation
of the CSNAT intervention and are testing this in an
implementation study with improved results.
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